tm
Seeing Is Believing
tm
Seeing Is Believing
SLS is currently covered by 1 analysts with an average price target of $30.43. This is a potential upside of $26.97 (779.48%) from yesterday's end of day stock price of $3.46.
Sellas Life Sciences Group's activity chart (see below) currently has 20 price targets and 15 ratings on display. The stock rating distribution of SLS is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 23% with an average time for these price targets to be met of 266 days.
Highest price target for SLS is $7, Lowest price target is $7, average price target is $7.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 16-Jul-2025. First documented stock forecast 02-Apr-2018.
Currently out of the existing stock ratings of SLS, 1 are a BUY (100%).
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 22-Dec-2020
$7
$3.54 (102.31%)
$4
5 months 25 days ago
(16-Jul-2025)
3/4 (75%)
$5.08 (264.58%)
524
Buy
Since 07-Feb-2022
$6
$2.54 (73.41%)
$13
1 years 7 months 25 days ago
(16-May-2024)
0/3 (0%)
$4.53 (308.16%)
Buy
Since 21-Jul-2021
$3
$-0.46 (-13.29%)
$3
2 years 1 months 19 days ago
(22-Nov-2023)
2/5 (40%)
$1.99 (197.03%)
806
Buy
$8
$6.97 (676.70%)
$14
3 years 1 months 26 days ago
(15-Nov-2022)
0/3 (0%)
$5.76 (257.14%)
Buy
Since 02-Apr-2018
$550
$546.54 (15795.95%)
7 years 9 months 8 days ago
(02-Apr-2018)
0/1 (0%)
$117.5 (27.17%)
What is SLS (Sellas Life Sciences Group) average time for price targets to be met?
Which analyst has the current highest performing score on SLS (Sellas Life Sciences Group) with a proven track record?
Which analyst has the current lower performing score on SLS (Sellas Life Sciences Group) with a proven track record?
Which analyst has the most public recommendations on SLS (Sellas Life Sciences Group)?
Which analyst is the currently most bullish on SLS (Sellas Life Sciences Group)?
Which analyst is the currently most reserved on SLS (Sellas Life Sciences Group)?
